Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
HER2 Levels May Aid In Treatment Selection For Metastatic Breast Cancer
http://www.medicalnewstoday.com/articles/131645.php
Findings published in the December 1, 2008, issue of <a href="http://clincancerres.aacrjournals.org/" target="_blank" rel="nofollow"><i>Clinical Cancer Research</i> </a>, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit.
Studies Evaluate Breast Cancer Outcomes In Older Patients, Women With Breast Augmentations
http://www.medicalnewstoday.com/articles/131558.php
<BR>The following summarizes news coverage of two recent studies on breast cancer treatment.<BR /><BR />~ Older Patients: One in five women ages 65 and older delayed or did not complete their full radiation regimen after breast-conserving surgery, leading to an increased risk of death or recurrence, according to a <A href="http://www3.
New Mammography Technology Effective In Detecting Breast Cancer
http://www.medicalnewstoday.com/articles/131533.php
A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer.
Linda Creed Announces Volunteer Recognition Awards
http://www.medicalnewstoday.com/articles/131514.php
Linda Creed, an affiliate of Public Health Management Corporation (PHMC), will hold their annual Volunteer Recognition Awards this Saturday, December 6 at 11 a.m. The awards are given in recognition of individuals, corporations, and health organizations that have made a significant difference in the ability to provide access to basic breast health in the region.
----------------------------------------------
** CANCER / ONCOLOGY News **
PharmaEngine Receives Approval Of US IND Application For A Phase II Study Of PEP02 (Liposome Irinotecan Injection) In Pancreatic Cancer
http://www.medicalnewstoday.com/articles/131686.php
PharmaEngine, Inc. announced today that it has received approval of an Investigational New Drug (IND) application from the U.S. FDA for PEP02, a liposome formulation of irinotecan in a phase II study in patients with metastatic pancreatic cancer.
Blood Scanner That Detects Even Faint Indicators Of Cancer Developed By Stanford Researchers
http://www.medicalnewstoday.com/articles/131670.php
A team led by Stanford researchers has developed a prototype blood scanner that can find cancer markers in the bloodstream in early stages of the disease, potentially allowing for earlier treatment and dramatically improved chances of survival.
HER2 Levels May Aid In Treatment Selection For Metastatic Breast Cancer
http://www.medicalnewstoday.com/articles/131645.php
Findings published in the December 1, 2008, issue of <a href="http://clincancerres.aacrjournals.org/" target="_blank" rel="nofollow"><i>Clinical Cancer Research</i> </a>, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit.
Behavior And Screening Have Biggest Impact On Drop In Cancer Deaths
http://www.medicalnewstoday.com/articles/131639.php
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
Recurring Brain Tumors Are Treated Effectively By Gamma Knife - South Nassau Communities Hospital
http://www.medicalnewstoday.com/articles/131598.php
According to a study conducted by radiation oncologists at the Cleveland Clinic, stereotactic radiosurgery (SRS) performed on recurring brain tumors proved effective at extending the survival of the patient and controlling the tumor.
Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine For Injection) And Vidaza(R) (azacitidine)
http://www.medicalnewstoday.com/articles/131530.php
Eisai Corporation of North America announced that it plans to initiate the first clinical trial evaluating the activity of Dacogen(R) (decitabine for injection) compared to Vidaza(R) (azacitidine) in adult patients with intermediate-1, intermediate-2 or high-risk myelodysplastic syndromes (MDS), a potentially life-threatening group of bone marrow diseases that limit the production of functional blood cells.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Survival Rates In Advanced Rectal Cancer Patients May Be Improved By Preoperative Radiation
http://www.medicalnewstoday.com/articles/131673.php
Patients treated with radiation prior to surgery for advanced rectal cancer have fewer instances of cancer recurrence and better overall survival rates, according to a recent Geisinger report.
1-Stop Screening For Cancer And Osteoporosis
http://www.medicalnewstoday.com/articles/131649.php
New research reveals that computed tomography (CT) colonography, also known as virtual colonoscopy, has the potential to screen for two diseases at once - colorectal cancer and osteoporosis, both of which commonly affect adults over age 50.
----------------------------------------------
** LUNG CANCER News **
Identification Of Gene Which Protects Against Lung Cancer
http://www.medicalnewstoday.com/articles/131640.php
A study led by researchers at The University of Nottingham has identified a gene that protects the body from lung cancer.The research, published in the journal <i>Proceedings of the National Academy of Sciences</i>, USA and funded by a £72,000 grant from the British Lung Foundation, has found that the tumour suppressor gene, LIMD1, is responsible for protecting the body from developing lung cancer - paving the way for possible new treatments and early screening techniques.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
OGX-011 Shows Overall Survival Advantage In Prostate Cancer Compared To Standard Therapy In A Randomized Phase 2 Study
http://www.medicalnewstoday.com/articles/131681.php
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone ("the OGX-011 arm") compared to docetaxel and prednisone alone ("the control arm") for first-line treatment of metastatic castrate resistant prostate cancer.
USHIFU Announces First Sonablate(R) HIFU Device In India For Minimally Invasive Prostate Cancer Treatment
http://www.medicalnewstoday.com/articles/131539.php
USHIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies, announced the establishment of India HIFU and the launch of Sonablate(R) HIFU services in Hyderabad, India at Dr.
Phase II Study Shows That ZD4054 Could Improve Survival For Hormone Resistant Prostate Cancer (HRPC) Patients With Bone Metastases
http://www.medicalnewstoday.com/articles/131481.php
A novel compound in development by AstraZeneca as an oral tablet for hormone resistant prostate cancer (HRPC), ZD4054, could improve overall survival (OS) in men with metastatic HRPC, according to Phase II data published today in <i>European Urology.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment